Cargando…
Parálisis de Bell secundaria a vacuna para covid-19 Pfizer: reporte de caso
BACKGROUND: BNT162b2 (Pfizer-BioNTech) is a nucleoside-modified mRNA vaccine formulated with lipid nanoparticles for the prevention of COVID-19 disease caused by SARS-CoV-2 infection. In early December 2020, BNT162b2 received an emergency use authorization, initial efficacy and safety data have been...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Instituto Mexicano del Seguro Social
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396063/ https://www.ncbi.nlm.nih.gov/pubmed/35759681 |